openPR Logo
Press release

Humanized Liver Mice Model Market Poised for Significant Growth Through 2032 | Persistence Market Research

04-17-2025 09:14 AM CET | Health & Medicine

Press release from: Persistence Market Research

Humanized Liver Mice Model Market

Humanized Liver Mice Model Market

Overview of the Humanized Liver Mice Model Market

The global humanized liver mice model market is growing rapidly, driven by the increasing demand for advanced preclinical models in drug testing, liver disease research, and personalized medicine. Humanized liver mice models, genetically engineered to contain human liver cells, allow researchers to simulate human liver functions and diseases more accurately than traditional animal models. This is crucial for understanding the mechanisms of liver diseases such as hepatitis, cirrhosis, and liver cancer, as well as testing the efficacy and safety of new drugs. The market's growth is primarily fueled by advancements in biotechnology, increasing research funding, and a rising number of pharmaceutical companies focused on liver disease therapeutics.

The market is expected to experience significant growth due to the increasing adoption of humanized liver mice models in drug discovery, regenerative medicine, and toxicology testing. Key growth drivers include the growing prevalence of liver diseases, advancements in genetic engineering techniques, and increased collaboration between academic and industry players. North America currently leads the global market due to its robust healthcare infrastructure, high levels of research investment, and established pharmaceutical industry. The region's dominance is further strengthened by the presence of leading biotech companies and government initiatives supporting innovative medical research.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/25417

Key Highlights from the Report:

• The humanized liver mice model market is projected to expand significantly in the coming years.
• North America is expected to dominate the global market share due to its advanced healthcare ecosystem.
• Growing prevalence of liver diseases globally is driving demand for more accurate preclinical models.
• Advancements in genetic engineering technologies are improving the development of humanized liver mice models.
• The pharmaceutical industry is the leading end-user segment, contributing to market growth.
• Asia-Pacific is anticipated to experience the fastest growth during the forecast period.

Market Segmentation

The humanized liver mice model market can be segmented based on product type, end-users, and geographical regions. Product type is one of the most crucial segments, encompassing various types of humanized mice models such as chimeric models and knockout models. Chimeric humanized liver mice are those that have human liver cells transplanted into them, enabling better simulation of human liver functions. Knockout models are genetically modified to lack certain genes, helping researchers study the effects of gene deficiencies on liver function. Both models have their unique applications in different research areas, including drug testing and gene therapy.

Another important segmentation category is end-users, which includes pharmaceutical and biopharmaceutical companies, academic and research institutions, and contract research organizations (CROs). Pharmaceutical companies are the dominant end-users due to their ongoing drug discovery processes and the necessity of using humanized animal models to evaluate drug safety and efficacy. Academic and research institutions also account for a significant portion of the market, as they conduct studies to further understand liver diseases and create novel therapies. Contract research organizations provide outsourced testing services and have become essential partners for pharmaceutical companies in drug development.

Regional Insights

The global market for humanized liver mice models is geographically diverse, with North America leading the market due to its strong healthcare infrastructure, technological advancements, and government funding supporting biomedical research. The region's extensive pharmaceutical industry and research initiatives further contribute to the demand for sophisticated animal models.

In contrast, the Asia-Pacific region is experiencing rapid growth, driven by increasing research activities in countries like China and Japan. These countries have made significant advancements in biotechnology and have witnessed a rise in the number of contract research organizations. Additionally, the growing focus on healthcare and liver disease research in emerging economies is expected to boost the demand for humanized liver mice models in the region.

Market Drivers

One of the primary drivers of the humanized liver mice model market is the increasing prevalence of liver diseases worldwide. Chronic liver conditions such as hepatitis, cirrhosis, and liver cancer are on the rise, creating a pressing need for more effective treatment options. Humanized liver mice models allow for more accurate preclinical testing of drug candidates, improving the likelihood of successful outcomes in clinical trials.

Advancements in genetic engineering technologies also play a pivotal role in driving market growth. The ability to create more precise and reliable humanized models through genetic modification allows for better simulations of human liver conditions. These advancements are particularly valuable in toxicology testing, where accurate models are crucial for assessing the safety of new pharmaceutical compounds.

Market Restraints

Despite the promising growth prospects, the humanized liver mice model market faces several challenges. One of the main constraints is the high cost associated with developing and maintaining these models. The genetic engineering required to create humanized mice models is complex and expensive, limiting their widespread use, particularly in smaller research facilities or emerging markets.

Additionally, ethical concerns surrounding the use of animal models in research could hinder market growth. The scientific community and regulatory authorities are increasingly focused on reducing animal testing, which may impact the demand for animal-based models like humanized liver mice. The growing push for alternative methods, such as organ-on-a-chip technology, could pose a challenge to the traditional reliance on animal models.

Market Opportunities

The market offers several opportunities driven by the ongoing advancements in biotechnology. The development of more sophisticated and accurate humanized liver mice models will open new avenues for studying complex liver diseases and personalized medicine. These models can aid in the development of targeted therapies tailored to individual genetic profiles, which could revolutionize liver disease treatment.

Furthermore, there is a growing opportunity for market players to collaborate with pharmaceutical companies to create custom humanized liver mice models for specific drug discovery programs. By providing more specialized and accurate models, companies can cater to the unique needs of their clients, creating new revenue streams in the market.

Reasons to Buy the Report

✔ Comprehensive analysis of the humanized liver mice model market's growth potential.
✔ Insight into key trends and innovations shaping the market's future.
✔ Detailed information on market segmentation by product type and end-users.
✔ Analysis of regional market dynamics, including North America, Europe, and Asia-Pacific.
✔ Access to the latest market forecasts and expert insights on emerging opportunities.

Company Insights

Some of the key players in the humanized liver mice model market include:

• Charles River Laboratories
• Taconic Biosciences
• Envigo
• GenOway
• Jackson Laboratory
• Crown Bioscience

Recent Developments:

• Charles River Laboratories recently introduced a new range of genetically engineered humanized liver models to support pharmaceutical and toxicology testing.

• GenOway has expanded its portfolio of humanized liver mice models by developing models that integrate human hepatocytes, improving the precision of drug testing for liver diseases.

The humanized liver mice model market is on an upward trajectory, driven by advancements in biotechnology, increasing research needs, and the growing demand for more accurate and reliable preclinical models in the study of liver diseases and drug development. Despite challenges related to cost and ethical concerns, the market presents substantial growth opportunities, particularly in regions like North America and Asia-Pacific.

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Humanized Liver Mice Model Market Poised for Significant Growth Through 2032 | Persistence Market Research here

News-ID: 3975242 • Views:

More Releases from Persistence Market Research

Global Automotive Active Health Monitoring Systems Market Expected to Surge from US$ 683.9 Mn in 2025 to US$ 2,338.3 Mn by 2032 at 19.2% CAGR | Persistence Market Research
Global Automotive Active Health Monitoring Systems Market Expected to Surge from …
The Automotive Active Health Monitoring Systems Market is poised for significant growth over the forecast period of 2025 to 2032. This market is projected to expand from USD 683.9 million in 2025 to USD 2,338.3 million by 2032, registering a robust CAGR of 19.20%. Automotive active health monitoring systems are designed to track the real-time status of vehicles, enabling predictive maintenance, reducing downtime, and enhancing overall vehicle safety. With growing
Primary Packaging Labels Market to Reach US$12.2 Bn by 2031 with Steady Growth at 3.3% CAGR - Persistence Market Research
Primary Packaging Labels Market to Reach US$12.2 Bn by 2031 with Steady Growth a …
➤Overview of the Market The global primary packaging labels market is a crucial segment of the packaging industry, enabling product identification, regulatory compliance, and brand differentiation. Primary labels are applied directly on product packaging, such as bottles, vials, boxes, and pouches, serving both functional and promotional roles. As consumer awareness of product authenticity and safety continues to rise, demand for innovative labeling solutions is expanding. Moreover, stringent regulatory frameworks in industries
Shelf Stable Packaging Market to Reach US$10.7 Bn by 2031 with Steady Growth at 2.4% CAGR - Persistence Market Research
Shelf Stable Packaging Market to Reach US$10.7 Bn by 2031 with Steady Growth at …
➤Overview of the Market The shelf stable packaging market plays a critical role in extending the shelf life of food and beverages without the need for refrigeration, ensuring product safety, convenience, and affordability. These packaging solutions-spanning cartons, pouches, cans, and plastic containers-are widely used in ready-to-eat meals, dairy alternatives, sauces, soups, and beverages. Growth in the market is closely linked to evolving consumer lifestyles, increasing urbanization, and demand for long-lasting packaged
Print Label Market to Reach US$68.6 Bn by 2031 with Steady Growth at 4.3% CAGR - Persistence Market Research
Print Label Market to Reach US$68.6 Bn by 2031 with Steady Growth at 4.3% CAGR - …
➤Overview of the Market The global print label market is poised for substantial expansion, driven by increasing demand across industries such as food & beverages, pharmaceuticals, cosmetics, and logistics. Labels play a crucial role in brand identity, product differentiation, and regulatory compliance. In addition to providing essential information like product ingredients, expiration dates, and barcodes, printed labels serve as key marketing tools that influence consumer purchase decisions. With the rapid rise

All 5 Releases


More Releases for Humanized

2.5 Weeks to Deliver Desired Humanized Antibody in ProBio
500+ Antibody Humanization Projects Guarantee no loss of affinity The most advanced project is marketed Antibody humanization [https://www.probiocdmo.com/add-antibody-humanization.html] & antibody characterization can reduce the immunogenicity of monoclonal antibodies derived from xenogeneic sources and improve their activation of the human immune system by replacing non-human antibody frameworks with human ones. It is a very important step in the therapeutic antibody discovery process. ProBio is the world's No.1 fast antibody humanization service provider, providing 2
Humanized Liver Mice Model Market: Revolutionizing Biomedical Research with Cutt …
A large number of humanized liver mice models are available, including uPA-SCID mice, FRG KO mice, and TK-NOG mice, among others. Factors such as increasing incidence of liver cirrhosis, technological advancement and development of new humanized liver mice models, increase in number of FDA approvals for liver-based disease treatment dugs have increased the number of research and development activities, which require these models. However, the high cost of mice models as
Humanized Mouse Model Market to Discern Steadfast Expansion During 2031
Global Humanized Mouse Model Market: Snapshot The global humanized mouse model market is estimated to gain a valuation of US$ 188.57 Mn by 2027. Thus, the market for humanized mouse model is projected to expand at a CAGR of 9.54% during the forecast period of 2020 to 2027. The total valuation of the humanized mouse model market was US$ 95.72 Mn in 2019. Humanized mouse models are used in by a wide
Humanized Mouse Model Market 2022 | Detailed Report
The Humanized Mouse Model report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry. The Humanized Mouse Model report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,
Global Cell-based Humanized Mouse Models Market Technology Updates by Top Indust …
Syndicate Market Research recently launched a study report on the global Cell-based Humanized Mouse Models market project light on the significant drifts and vigorous cannon into the evolution of the trade, which includes the restraints, market drivers, and opportunities. The report talks about the competitive environment prevailing in the Cell-based Humanized Mouse Models market worldwide. The report lists the key players in the market and also provides insightful information about
Humanized Mouse Model Market Overview and Report forecast 2025
Humanized mouse models are used for basic research, safety assessment for large molecule therapeutics, modeling of certain human-specific infectious diseases, and efficacy testing of immunotherapy approaches. The human protein is expressed while the mouse protein is suppressed in all cells and tissues. Humanized mouse models are important tools required to conduct preclinical research, mimic human pathological conditions, test compound efficacy, and measure its effects on human proteins. The model requires